Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_68590
http://purl.obolibrary.org/obo/CHEBI_68590
|
|---|---|
| Preferred Name | fidaxomicin |
| Synonyms |
C52H74Cl2O18
Tiacumicin B
(2R,3S,4S,5S,6R)-6-{[(3E,5E,8S,9E,11S,12R,13E,15E)-12-{[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy}-4-hydroxy-5-methoxy-2-methyloxan-3-yl 3,5-dichloro-6-ethyl-2,4-dihydroxybenzoate
PAR-101
OPT 80
Lipiarmycin
Dificid
OPT-80
PAR 101
Lipiarmicin
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | fidaxomicin
|
|---|---|
| label | fidaxomicin
|
| DBSynonym |
tiacumicin b
difimicin
lipiarrmycin
opt-80
par-101
|
| ATCCode | A07AA12
|
| Definition | One of the first narrow spectrum macrocyclic antibiotic, it is a natural compound and is structurally similar to compounds in lipiarmycin-a fermentation mixture. FDA approved on May 27, 2011.
An 18-membered macrolide that is a fermentation product obtained from the Actinomycete Dactylosporangium aurantiacum. A narrow spectrum antibiotic used for treatment of Clostridium difficile-related infections.
|
| has pharmacological target | |
| inhibits | |
| type | |
| has role | |
| InChIKey | InChIKey=ZVGNESXIJDCBKN-KFGPIHIUSA-N
|
| AHFScode | 8:12.12.92
|
| Synonym | C52H74Cl2O18
Tiacumicin B
(2R,3S,4S,5S,6R)-6-{[(3E,5E,8S,9E,11S,12R,13E,15E)-12-{[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy}-4-hydroxy-5-methoxy-2-methyloxan-3-yl 3,5-dichloro-6-ethyl-2,4-dihydroxybenzoate
PAR-101
OPT 80
Lipiarmycin
Dificid
OPT-80
PAR 101
Lipiarmicin
See more
See less
|
| xref |
CiteXplore:22523271
CiteXplore:22752858
CiteXplore:22321770
CiteXplore:22290948
Patent:WO2006085838
CiteXplore:22702523
CiteXplore:22752862
CiteXplore:20509714
CiteXplore:22752865
CiteXplore:22508299
CiteXplore:22752863
Drugs.com:http://www.drugs.com/ppa/fidaxomicin.html
KEGG DRUG:D09394
CiteXplore:22752860
CiteXplore:22318930
CASRN:873857-62-6
Patent:US2008269145
CiteXplore:22752861
Wikipedia:http://en.wikipedia.org/wiki/Fidaxomicin
CiteXplore:22610025
CiteXplore:22284993
CiteXplore:22260856
CiteXplore:22156854
ChEBI:68590
Reaxys:12687773
CiteXplore:22752859
Wikipedia:Fidaxomicin
CiteXplore:22752871
CiteXplore:22708825
RxList:http://www.rxlist.com/dificid-drug.htm
CiteXplore:22865382
CiteXplore:22384450
National Drug Code Directory:52015-080-01
See more
See less
|
| CASRN | 873857-62-6
|
| prefixIRI | obo2:CHEBI_68590
|
| is transported by | |
| SMILES | CC[C@H]1\C=C(C)\[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)C3=C(CC)C(Cl)=C(O)C(Cl)=C3O)[C@H](O)[C@@H]2OC)\C(=O)OC(C\C=C(/C)\C=C(C)\[C@@H]1O[C@@H]1OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O)[C@@H](C)O
CC[C@H]1\\C=C(C)\\[C@@H](O)C\\C=C\\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)c3c(O)c(Cl)c(O)c(Cl)c3CC)[C@H](O)[C@@H]2OC)\\C(=O)OC(C\\C=C(C)\\C=C(C)\\[C@@H]1O[C@@H]1OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O)[C@@H](C)O
|
| may interact with | |
| InChI | InChI=1S/C52H74Cl2O18/c1-13-30-22-26(6)33(56)18-16-15-17-31(23-66-51-45(65-12)42(61)44(29(9)67-51)69-49(64)35-32(14-2)36(53)39(58)37(54)38(35)57)48(63)68-34(28(8)55)20-19-25(5)21-27(7)43(30)70-50-41(60)40(59)46(52(10,11)72-50)71-47(62)24(3)4/h15-17,19,21-22,24,28-30,33-34,40-46,50-51,55-61H,13-14,18,20,23H2,1-12H3/b16-15+,25-19+,26-22+,27-21+,31-17+/t28-,29-,30+,33+,34?,40-,41+,42+,43+,44-,45+,46+,50-,51-/m1/s1
|
| DBBrand | dificid
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |